Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-20-019954

Chief Commercial Officer bought 2,000 shares at $4.25 ($8,500)

From the SEC's structured data for this filing

Trades in this filing

Millian Craig Stuart · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-03-17 Purchase : show line 1 in the form +2,000 $4.25 $8,500 12,000 D
Open-market purchases · 2,000 sh · avg $4.25 · $8,500
Loading xslF345X03/doc4.xml…